Literature DB >> 27797880

Ventricular fibrillation via torsade des pointes of cardiac sarcoidosis with preserved left ventricular ejection fraction.

Takayuki Sekihara1, Eisaku Nakane1, Kazutaka Nakasone1, Moriaki Inoko1.   

Abstract

Generally, low left ventricular ejection fraction (LVEF) is a risk for ventricular arrhythmia in patients with cardiac sarcoidosis. We present a case of cardiac sarcoidosis with preserved LVEF that evoked ventricular fibrillation (VF). A 73-year-old woman with VF presented to our emergency department. She had a history of ocular sarcoidosis, with gradual thinning of the basal intraventricular septum. LVEF was 62% on the most recent echocardiography. The electrocardiogram after defibrillation showed complete atrioventricular block (CAVB) with QT segment prolongation and frequent ventricular premature beats. VF via torsade des pointes (TdP) was suspected, and temporary intravenous ventricular pacing and magnesium sulfate infusion suppressed her VF. Cardiac sarcoidosis was diagnosed, and an implantable cardioverter defibrillator was implanted. Patients with cardiac sarcoidosis with CAVB are at risk of evoking VF via TdP regardless of LVEF. If cardiac sarcoidosis is suspected, early diagnosis and risk stratification of ventricular arrhythmia are important. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27797880      PMCID: PMC5093745          DOI: 10.1136/bcr-2016-216936

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  Predictive factors of ventricular fibrillation triggered by pause-dependent torsades de pointes associated with acquired long QT interval: role of QT dispersion and left ventricular function.

Authors:  A Da Costa; T Chalvidan; A Belounas; M Messier; M Viallet; H Mansour; D Lamaison; P Djiane; K Isaaz
Journal:  J Cardiovasc Electrophysiol       Date:  2000-09

2.  Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias.

Authors:  Thomas Crawford; Gisela Mueller; Sinan Sarsam; Hutsaya Prasitdumrong; Naiyanet Chaiyen; Xiaokui Gu; Joseph Schuller; Jordana Kron; Khaled A Nour; Alan Cheng; Sang Yong Ji; Shawn Feinstein; Sanjaya Gupta; Karl Ilg; Mohamad Sinno; Saddam Abu-Hashish; Mouaz Al-Mallah; William H Sauer; Kenneth Ellenbogen; Fred Morady; Frank Bogun
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-09-29

3.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

4.  HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis.

Authors:  David H Birnie; William H Sauer; Frank Bogun; Joshua M Cooper; Daniel A Culver; Claire S Duvernoy; Marc A Judson; Jordana Kron; Davendra Mehta; Jens Cosedis Nielsen; Amit R Patel; Tohru Ohe; Pekka Raatikainen; Kyoko Soejima
Journal:  Heart Rhythm       Date:  2014-05-09       Impact factor: 6.343

5.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

6.  Electrocardiographic predictors of bradycardia-induced torsades de pointes in patients with acquired atrioventricular block.

Authors:  Min Soo Cho; Gi-Byoung Nam; Yong-Guin Kim; Ki-Won Hwang; Yoo Ri Kim; HyungOh Choi; Sung-Hwan Kim; Kyoung-Suk Rhee; Nam-Joon Kim; June Soo Kim; Jun Kim; Kee-Joon Choi; You-Ho Kim
Journal:  Heart Rhythm       Date:  2014-11-18       Impact factor: 6.343

7.  Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators.

Authors:  Brian P Betensky; Cory M Tschabrunn; Erica S Zado; Lee R Goldberg; Francis E Marchlinski; Fermin C Garcia; Joshua M Cooper
Journal:  Heart Rhythm       Date:  2012-02-13       Impact factor: 6.343

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.